|
|
Article: Ortho Biotech's SPORANOX injection available to treat potentially life-threatening fungal infections.
- Article from:
- Transplant News
- Article date:
- February 29, 2000
CopyrightCOPYRIGHT 2000 Transplant Communications, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Ortho Biotech, Inc., Raritan, NJ, announced SPORANOX (itraconazole) Injection is now available for treatment of potentially life-threatening fungal infections, including blatomycosis, histoplasmosis, and aspergillosis in patients who are intolerant of or refractory to amphotericin B, a first line therapy. ...
Related newspaper, magazine, and journal articles:
|
|
Article: Xoma and Johnson and Johnson unit announce agreement. ...
PR Newswire;
March 19, 1990 ;
700+ words
... ... Corp. (NASDAQ/NMS: XOMA) and Ortho Biotech, a division of Johnson & Johnson ... solid organ transplantation, with Ortho Biotech having the opportunity to acquire rights ... manufacturing rights for both products. Ortho Biotech has worldwide marketing rights except ...
|
|